Patents by Inventor Kent W. Leyde

Kent W. Leyde has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11406317
    Abstract: Methods for detecting neurological and clinical manifestations of a seizure are provided. Systems are described including a monitoring device having a communication assembly for receiving neurological data transmitted external to a patient from a transmitter implanted in a patient; a processor that processes the neurological data to estimate the patient's brain state; and an assembly for automatically recording clinical manifestation data in response to a brain state estimate by the processor.
    Type: Grant
    Filed: February 25, 2015
    Date of Patent: August 9, 2022
    Assignee: LivaNova USA, Inc.
    Inventors: Kent W. Leyde, Michael Bland
  • Patent number: 9898656
    Abstract: The invention provides a method of monitoring a subject's neurological condition. In some embodiments, the method includes the steps of analyzing a physiological signal (such as an EEG) from a subject to determine if the subject is in a contra-ictal condition; and if the subject is in a contra-ictal condition, providing an indication (e.g., to the subject and/or to a caregiver) that the subject is in the contra-ictal condition, such as by activating a green light or other visible output. In some embodiments, if the subject is in a pro-ictal condition, the method includes the step of providing an indication (such as a red light) that the subject is in the pro-ictal condition. The invention also provides neurological system monitors.
    Type: Grant
    Filed: January 25, 2008
    Date of Patent: February 20, 2018
    Assignee: Cyberonics, Inc.
    Inventors: David Snyder, Kent W. Leyde, John F. Harris
  • Patent number: 9788744
    Abstract: A patient advisory device (“PAD”) and its methods of use. The PAD may be configured to alert the patient about an estimated brain state of the patient. In preferred embodiments, the PAD is adapted to alert the patient of the patient's brain state, which corresponds to the patient's propensity of transitioning into an ictal brain state, e.g., having a seizure. Based on the specific type of alert, the patient will be made aware whether they are highly unlikely to have a seizure for a given period of time, an elevated propensity of having a seizure, a seizure is occurring or imminent, or the patient's brain state is unknown.
    Type: Grant
    Filed: July 28, 2008
    Date of Patent: October 17, 2017
    Assignee: CYBERONICS, INC.
    Inventors: Michael Bland, Kent W. Leyde, Neil G. McIlvaine, Shan Gaw, Peter Weiss, John F. Harris
  • Patent number: 9643019
    Abstract: A system for providing alerts of neurological events occurring in a human subject is provided. The system includes: a monitoring module adapted to detect and sample a neurological signal; an event detection module coupled to the monitoring module for detecting one or more types of predetermined reportable events based on the detected neurological signal; and an alert module coupled to the event detection module, wherein upon the detection of a reportable event by the event detection module, said alert module selects a first alert contact from a plurality of contacts contained in a contact list, and generates a first alert communication to the first alert contact.
    Type: Grant
    Filed: February 14, 2011
    Date of Patent: May 9, 2017
    Assignee: CYBERONICS, INC.
    Inventors: Jason A. Higgins, Michael Bland, Kent W. Leyde, W. Douglas Sheffield, John F. Harris, David M. Himes
  • Patent number: 9622675
    Abstract: Systems and methods for monitoring neurological signals in a patient are provided. The system includes: an implantable sensor adapted to collect neurological signals; an implantable assembly configured to sample the neurological signals collected by the sensor; and a rechargeable communication device external to the patient's body, said communication device configured to wirelessly communicate with the implantable assembly and to transmit a communication error alert to a caregiver advisory device in the event of a communication error between the implantable assembly and the communication device.
    Type: Grant
    Filed: March 23, 2011
    Date of Patent: April 18, 2017
    Assignee: CYBERONICS, INC.
    Inventors: Kent W. Leyde, John F. Harris
  • Patent number: 9592004
    Abstract: The present invention provides systems and methods for managing epilepsy. In one embodiment, a method of the present invention characterize a patient's propensity for a future epileptic seizure and communicates to the patient and/or a health care provider a therapy recommendation. The therapy recommendation is typically a function of the patient's propensity for the future epileptic seizure.
    Type: Grant
    Filed: March 28, 2016
    Date of Patent: March 14, 2017
    Assignee: CYBERONICS, INC.
    Inventors: Daniel J. DiLorenzo, Kent W. Leyde
  • Patent number: 9480845
    Abstract: A wearable medical device system having an external, necklace-shaped antenna that is sized and configured for placement about the neck of a subject, and having an implantable device with an implanted antenna that communicates with the external antenna to permit the transfer of energy and data between external and implantable components. The wearable medical device includes a control module that communicates with the implanted device via the external antenna. The implantable device includes an electrode configured to provide stimulation to a nerve.
    Type: Grant
    Filed: March 10, 2015
    Date of Patent: November 1, 2016
    Assignee: CYBERONICS, INC.
    Inventors: John F. Harris, Kent W. Leyde
  • Patent number: 9445730
    Abstract: Systems and methods of monitoring a subject's neurological condition are provided. In some embodiments, the method includes the steps of analyzing a physiological signal (such as an EEG) from a subject to determine if the subject is in a contra-ictal condition; and if the subject is in a contra-ictal condition, providing an indication (e.g., to the subject and/or to a caregiver) that the subject is in the contra-ictal condition. The systems and methods may utilize a minimally invasive, leadless device to monitor the subject's condition. In some embodiments, if the subject is in a pro-ictal condition, the method includes the step of providing an indication (such as a red light) that the subject is in the pro-ictal condition.
    Type: Grant
    Filed: September 9, 2013
    Date of Patent: September 20, 2016
    Assignee: CYBERONICS, INC.
    Inventors: David Snyder, Kent W. Leyde, John F. Harris
  • Publication number: 20160206236
    Abstract: The present invention provides systems and methods for managing epilepsy. In one embodiment, a method of the present invention characterize a patient's propensity for a future epileptic seizure and communicates to the patient and/or a health care provider a therapy recommendation. The therapy recommendation is typically a function of the patient's propensity for the future epileptic seizure.
    Type: Application
    Filed: March 28, 2016
    Publication date: July 21, 2016
    Applicant: CYBERONICS, INC.
    Inventors: Daniel J. DILORENZO, Kent W. LEYDE
  • Publication number: 20160144163
    Abstract: A wire and electrode combination suitable for use with implanted medical devices, and a method for coupling the wire and electrode to achieve a robust electrical connection suitable for use with such medical devices are disclosed. The apparatus employs a wire that is optimized for strength, an electrode optimized for biocompatibility, and a termination sleeve with a closed distal end for coupling the wire to the electrode, while eliminating the potential for galvanic corrosion, enhancing weld quality, and facilitating manufacture of the apparatus. The method involves compressing the sleeve to engage the wire at two locations, where contact between the sleeve and wire at the first location seals the interior of the sleeve, and contact between the sleeve and wire at the second location electrically couples the wire to the sleeve. The sleeve, which is easier to manipulate than the wire, is then spot welded to the electrode.
    Type: Application
    Filed: January 28, 2016
    Publication date: May 26, 2016
    Inventors: Jared Floyd, Christopher Genau, Kent W. Leyde
  • Patent number: 9289595
    Abstract: A wire and electrode combination suitable for use with implanted medical devices, and a method for coupling the wire and electrode to achieve a robust electrical connection suitable for use with such medical devices are disclosed. The apparatus employs a wire that is optimized for strength, an electrode optimized for biocompatibility, and a termination sleeve with a closed distal end for coupling the wire to the electrode, while eliminating the potential for galvanic corrosion, enhancing weld quality, and facilitating manufacture of the apparatus. The method involves compressing the sleeve to engage the wire at two locations, where contact between the sleeve and wire at the first location seals the interior of the sleeve, and contact between the sleeve and wire at the second location electrically couples the wire to the sleeve. The sleeve, which is easier to manipulate than the wire, is then spot welded to the electrode.
    Type: Grant
    Filed: November 18, 2013
    Date of Patent: March 22, 2016
    Assignee: CYBERONICS, INC.
    Inventors: Jared Floyd, Christopher Genau, Kent W. Leyde
  • Patent number: 9259591
    Abstract: An implantable medical device having a concave ceramic housing component; a concave metal housing component attached to the ceramic housing component to form a hermetically sealed enclosure; and an electronic trans-housing magnetic flux component disposed within the enclosure. Another aspect of the invention provides an implantable medical device having a ceramic housing component; a metal housing component; a circumferential sealing member attached to a periphery of the ceramic housing component and to a periphery of the metal housing component to form a hermetically sealed enclosure; and an electronic trans-housing magnetic flux component disposed within the enclosure.
    Type: Grant
    Filed: December 23, 2008
    Date of Patent: February 16, 2016
    Assignee: CYBERONICS, INC.
    Inventors: David Brown, Christopher Genau, Kent W. Leyde, Shan Gaw, Jeffrey Stewart
  • Publication number: 20150216469
    Abstract: The present invention provides systems and methods for managing epilepsy. In one embodiment, a method of the present invention characterize a patient's propensity for a future epileptic seizure and communicates to the patient and/or a health care provider a therapy recommendation. The therapy recommendation is typically a function of the patient's propensity for the future epileptic seizure.
    Type: Application
    Filed: April 17, 2015
    Publication date: August 6, 2015
    Inventors: Daniel J. DiLorenzo, Kent W. Leyde
  • Publication number: 20150182753
    Abstract: A wearable medical device system having an external, necklace-shaped antenna that is sized and configured for placement about the neck of a subject, and having an implantable device with an implanted antenna that communicates with the external antenna to permit the transfer of energy and data between external and implantable components. The wearable medical device includes a control module that communicates with the implanted device via the external antenna. The implantable device includes an electrode configured to provide stimulation to a nerve.
    Type: Application
    Filed: March 10, 2015
    Publication date: July 2, 2015
    Inventors: John F. Harris, Kent W. Leyde
  • Publication number: 20150164403
    Abstract: Methods for detecting neurological and clinical manifestations of a seizure are provided. Systems are described including a monitoring device having a communication assembly for receiving neurological data transmitted external to a patient from a transmitter implanted in a patient; a processor that processes the neurological data to estimate the patient's brain state; and an assembly for automatically recording clinical manifestation data in response to a brain state estimate by the processor.
    Type: Application
    Filed: February 25, 2015
    Publication date: June 18, 2015
    Inventors: Kent W. Leyde, Michael Bland
  • Patent number: 9044188
    Abstract: The present invention provides systems and methods for managing epilepsy. In one embodiment, a method of the present invention characterize a patient's propensity for a future epileptic seizure and communicates to the patient and/or a health care provider a therapy recommendation. The therapy recommendation is typically a function of the patient's propensity for the future epileptic seizure.
    Type: Grant
    Filed: May 12, 2014
    Date of Patent: June 2, 2015
    Assignee: CYBERONICS, INC.
    Inventors: Daniel J. DiLorenzo, Kent W. Leyde
  • Patent number: 8868172
    Abstract: The present invention provides methods and system for managing neurological disorders such as epilepsy. In one embodiment, the method comprises measuring one or more signals from a patient and processing the one or more signals to characterize a patient's propensity for a future seizure. The characterized propensity for the seizure is thereafter used to determine an appropriate action for managing or treating the predicted seizure; and a recommendation is communicated to the patient that is indicative of the appropriate action.
    Type: Grant
    Filed: December 28, 2005
    Date of Patent: October 21, 2014
    Assignee: Cyberonics, Inc.
    Inventors: Kent W. Leyde, Daniel J. Dilorenzo
  • Patent number: 8855775
    Abstract: Systems and methods for neuromonitoring a subject are described. The system may include a stimulation assembly including a pulse generator that generates one or more stimulus waveforms; an electrode array coupled to the stimulation assembly and configured to deliver a stimulation signal to nervous system of the subject; a sensing assembly adapted to acquire a signal from a subject indicative of the subject's brain activity; a power supply configured to supply power to the stimulation assembly and the sensing assembly; and a timing controller programmed to control the use of the power supply by the stimulation assembly and the sensing assembly, said timing controller being programmed to control the time the sensing assembly is powered to acquire the signal to be substantially different than the time the stimulation assembly is powered to stimulate the subject.
    Type: Grant
    Filed: October 23, 2012
    Date of Patent: October 7, 2014
    Assignee: Cyberonics, Inc.
    Inventor: Kent W. Leyde
  • Patent number: 8849390
    Abstract: Method and apparatus for improved processing for multi-channel signals. In an exemplary embodiment, an anomaly metric is computed for a multi-channel signal over a time window. The magnitude of the anomaly metric may be used to determine whether an anomaly is present in the multi-channel signal over the time window. In an exemplary embodiment, the anomaly metric may be a condition number associated with the singular values of the multi-channel signal over the time window, as further adjusted by the number of channels to produce a data condition number. Applications of the anomaly metric computation include the scrubbing of signal archives for epileptic seizure detection/prediction/counter-prediction algorithm training, pre-processing of multi-channel signals for real-time monitoring of bio-systems, and boot-up and/or adaptive self-checking of such systems during normal operation.
    Type: Grant
    Filed: December 29, 2009
    Date of Patent: September 30, 2014
    Assignee: Cyberonics, Inc.
    Inventors: Javier Ramón Echauz, David E. Snyder, Kent W. Leyde
  • Publication number: 20140257118
    Abstract: The present invention provides systems and methods for managing epilepsy. In one embodiment, a method of the present invention characterize a patient's propensity for a future epileptic seizure and communicates to the patient and/or a health care provider a therapy recommendation. The therapy recommendation is typically a function of the patient's propensity for the future epileptic seizure.
    Type: Application
    Filed: May 12, 2014
    Publication date: September 11, 2014
    Applicant: CYBERONICS, INC.
    Inventors: Daniel J. DiLorenzo, Kent W. Leyde